[AMPK as a therapeutic target for metabolic syndrome].
Hernández-Puga G, Laguna-Maldonado KD, Gregg-García R, Barrera-Zárate G, López-Ortiz FD, Matuz-Mares D.
Hernández-Puga G, et al. Among authors: matuz mares d.
Rev Med Inst Mex Seguro Soc. 2020 Sep 1;58(5):612-621. doi: 10.24875/RMIMSS.M20000091.
Rev Med Inst Mex Seguro Soc. 2020.
PMID: 34520149
Spanish.